Skip to content
DataLookout
Menu

UCB Biopharma SRL clinical trial pipeline

Get alerts when UCB Biopharma SRL's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

9 trials changed in the last 30 days: 0 stopped, 0 with notable changes, 9 with minor changes only.

  1. Minor: Brivaracetam in Children and · Seizures Enrollment closed, study ongoing UCB Biopharma SRLPhase 3 NCT04715646
  2. Minor: MyVisionXT · Rozanolixizumab · Ocular Myasthenia Gravis Trial sites expanded: 7 → 18 locations UCB Biopharma SRLPhase 3 NCT07465289
  3. Minor: MyVision · Rozanolixizumab · Ocular Myasthenia Gravis Trial sites expanded: 29 → 36 locations UCB Biopharma SRLPhase 3 NCT07463521
  4. Minor: SCALA · 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Study · Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis Trial sites expanded: 23 → 26 locations UCB Biopharma SRLPhase 2 NCT07725939
  5. Minor: ATMOS · 24 to 52 Weeks Treatment to Evaluate The Efficacy And Safety of Galvokimig in Adult Study · Non-Cystic Fibrosis Bronchiectasis Trial sites expanded: 4 → 7 locations UCB Biopharma SRLPhase 2 NCT07720375
  6. Minor: ziMyG · Subcutaneous Zilucoplan · Generalized Myasthenia Gravis Primary completion pushed from Nov 16, 2026 to May 12, 2027 UCB Biopharma SRLPhase 2/3 NCT06055959
  7. Minor: PHOENYCS FLY · Dapirolizumab Pegol in Study · Moderately to Severely Active Systemic Lupus Erythematosus Trial sites expanded: 242 → 245 locations UCB Biopharma SRLPhase 3 NCT06617325
  8. Minor: Rozanolixizumab · Generalized Myasthenia Gravis Enrollment closed, study ongoing UCB Biopharma SRLPhase 4 NCT07246564
  9. Minor: Staccato Alprazolam in Study Participants 12 Years of Age and Older With Stereotypical Prolonged Seizures Primary and study completion pushed from Oct 31, 2026 to Mar 29, 2027 UCB Biopharma SRLPhase 3 NCT05077904
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-11-13 NCT07934472 A Study to Evaluate the Placental Transfer of Dapirolizumab Pegol to the Infant(s) From… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
6
Phase 2
3
Phase 2/3
1
Phase 3
16
Phase 4
1
Not charted: 1 active trial with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when UCB Biopharma SRL's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free